Cetuximab is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is approved to treat colorectal cancer and squamous cell carcinoma of the head and neck. It is also being studied in the treatment of other types of cancers, including multiple myeloma.

SparkCures ID 79
Developed By Eli Lilly and Company
Generic Name Cetuximab
Additional Names Erbitux
Treatment Classifications

Clinical Trials


There are no resources, links or videos to display for this treatment.